Icon (ICLR) Cash from Operations (2009 - 2026)
Icon's (ICLR) quarterly Cash from Operations came in at $281.3 million in Q2 2026, up 92.39% year-over-year from $146.2 million in Q2 2025, and up 68.42% quarter-over-quarter from $167.0 million in Q1 2026.
Analysis
Icon (ICLR) Cash from Operations (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Cash from Operations for 18 consecutive years, with $281.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 92.39% year-over-year to $281.3 million in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 4.07% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 13.67% from the prior year.
- Cash from Operations was $281.3 million for Q2 2026 at Icon, up from $167.0 million in the prior quarter.
- Over five years, Cash from Operations peaked at $714.8 million in Q4 2024 and troughed at -$59.4 million in Q4 2022.
- A 5-year average of $292.9 million and a median of $247.6 million in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 120.5% in 2022 and jumped 840.64% in 2023, its largest moves.
- Over 5 years, Cash from Operations stood at -$59.4 million in 2022, then jumped by 840.64% to $440.1 million in 2023, then jumped by 62.4% to $714.8 million in 2024, then declined by 11.34% to $633.7 million in 2025, then sank by 55.62% to $281.3 million in 2026.
- The last three Cash from Operations figures came in at $281.3 million (Q2 2026), $167.0 million (Q1 2026), and $633.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 162.01 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 281.27 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 179.73 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 28.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -44.27 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -492,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 281.27 Mn |
| Mar 31, 2026 | 167.01 Mn |
| Dec 31, 2025 | 633.73 Mn |
| Sep 30, 2025 | 387.60 Mn |
| Jun 30, 2025 | 146.20 Mn |
| Mar 31, 2025 | 268.24 Mn |
| Dec 31, 2024 | 714.78 Mn |
| Sep 30, 2024 | 402.67 Mn |
| Jun 30, 2024 | 218.59 Mn |
| Mar 31, 2024 | 327.08 Mn |
| Dec 31, 2023 | 440.13 Mn |
| Sep 30, 2023 | 341.52 Mn |
| Jun 30, 2023 | 203.88 Mn |
| Mar 31, 2023 | 175.50 Mn |
| Dec 31, 2022 | -59.43 Mn |
| Sep 30, 2022 | 213.78 Mn |
| Jun 30, 2022 | 182.05 Mn |
| Mar 31, 2022 | 226.92 Mn |
| Dec 31, 2021 | 289.82 Mn |
| Sep 30, 2021 | 298.97 Mn |